210 related articles for article (PubMed ID: 28943610)
1. Medication Trials for Hyperphagia and Food-Related Behaviors in Prader-Willi Syndrome.
Miller JL; Strong TV; Heinemann J
Diseases; 2015 Jun; 3(2):78-85. PubMed ID: 28943610
[TBL] [Abstract][Full Text] [Related]
2. Obesity management in Prader-Willi syndrome: current perspectives.
Crinò A; Fintini D; Bocchini S; Grugni G
Diabetes Metab Syndr Obes; 2018; 11():579-593. PubMed ID: 30323638
[TBL] [Abstract][Full Text] [Related]
3. Calorie seeking, but not hedonic response, contributes to hyperphagia in a mouse model for Prader-Willi syndrome.
Davies JR; Humby T; Dwyer DM; Garfield AS; Furby H; Wilkinson LS; Wells T; Isles AR
Eur J Neurosci; 2015 Aug; 42(4):2105-13. PubMed ID: 26040449
[TBL] [Abstract][Full Text] [Related]
4. Alteration of serum leptin and LEP/LEPR promoter methylation in Prader-Willi syndrome.
Wieting J; Jahn K; Buchholz V; Lichtinghagen R; Deest-Gaubatz S; Bleich S; Eberlein CK; Deest M; Frieling H
Psychoneuroendocrinology; 2022 Sep; 143():105857. PubMed ID: 35803048
[TBL] [Abstract][Full Text] [Related]
5. Prader-Willi syndrome: From genetics to behaviour, with special focus on appetite treatments.
Griggs JL; Sinnayah P; Mathai ML
Neurosci Biobehav Rev; 2015 Dec; 59():155-72. PubMed ID: 26475993
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of obesity in Prader-Willi syndrome.
Khan MJ; Gerasimidis K; Edwards CA; Shaikh MG
Pediatr Obes; 2018 Jan; 13(1):3-13. PubMed ID: 27863129
[TBL] [Abstract][Full Text] [Related]
7. Prader-Willi Syndrome and Schaaf-Yang Syndrome: Neurodevelopmental Diseases Intersecting at the
Fountain MD; Schaaf CP
Diseases; 2016 Jan; 4(1):. PubMed ID: 28933382
[TBL] [Abstract][Full Text] [Related]
8. Hypomethylation of the dopamine transporter (DAT) gene promoter is associated with hyperphagia-related behavior in Prader-Willi syndrome: A case-control study.
Wieting J; Jahn K; Eberlein CK; Bleich S; Frieling H; Deest M
Behav Brain Res; 2023 Jul; 450():114494. PubMed ID: 37182741
[TBL] [Abstract][Full Text] [Related]
9. Dietary Management for Adolescents with Prader-Willi Syndrome.
Miller JL; Tan M
Adolesc Health Med Ther; 2020; 11():113-118. PubMed ID: 32922110
[TBL] [Abstract][Full Text] [Related]
10. The Prader-Willi syndrome Profile: validation of a new measure of behavioral and emotional problems in Prader-Willi syndrome.
Dykens EM; Roof E; Hunt-Hawkins H
Orphanet J Rare Dis; 2024 Feb; 19(1):83. PubMed ID: 38395848
[TBL] [Abstract][Full Text] [Related]
11. Clinical Trials in Prader-Willi Syndrome: A Review.
Mahmoud R; Kimonis V; Butler MG
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768472
[TBL] [Abstract][Full Text] [Related]
12. Obesity in Prader-Willi syndrome: physiopathological mechanisms, nutritional and pharmacological approaches.
Muscogiuri G; Barrea L; Faggiano F; Maiorino MI; Parrillo M; Pugliese G; Ruggeri RM; Scarano E; Savastano S; Colao A;
J Endocrinol Invest; 2021 Oct; 44(10):2057-2070. PubMed ID: 33891302
[TBL] [Abstract][Full Text] [Related]
13. Hypothalamic neuropeptides and neurocircuitries in Prader Willi syndrome.
Correa-da-Silva F; Fliers E; Swaab DF; Yi CX
J Neuroendocrinol; 2021 Jul; 33(7):e12994. PubMed ID: 34156126
[TBL] [Abstract][Full Text] [Related]
14. Transcranial direct current stimulation reduces food-craving and measures of hyperphagia behavior in participants with Prader-Willi syndrome.
Bravo GL; Poje AB; Perissinotti I; Marcondes BF; Villamar MF; Manzardo AM; Luque L; LePage JF; Stafford D; Fregni F; Butler MG
Am J Med Genet B Neuropsychiatr Genet; 2016 Mar; 171B(2):266-75. PubMed ID: 26590516
[TBL] [Abstract][Full Text] [Related]
15. Prader-Willi syndrome: an update on obesity and endocrine problems.
Kim SJ; Cho SY; Jin DK
Ann Pediatr Endocrinol Metab; 2021 Dec; 26(4):227-236. PubMed ID: 34991300
[TBL] [Abstract][Full Text] [Related]
16. Disentangling ingestive behavior-related phenotypes in Prader-Willi syndrome: Integrating information from nonclinical studies and clinical trials to better understand the pathophysiology of hyperphagia and obesity.
Wevrick R
Physiol Behav; 2020 May; 219():112864. PubMed ID: 32156555
[TBL] [Abstract][Full Text] [Related]
17. The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria.
Gunay-Aygun M; Schwartz S; Heeger S; O'Riordan MA; Cassidy SB
Pediatrics; 2001 Nov; 108(5):E92. PubMed ID: 11694676
[TBL] [Abstract][Full Text] [Related]
18. Current and emerging therapies for managing hyperphagia and obesity in Prader-Willi syndrome: A narrative review.
Tan Q; Orsso CE; Deehan EC; Triador L; Field CJ; Tun HM; Han JC; Müller TD; Haqq AM
Obes Rev; 2020 May; 21(5):e12992. PubMed ID: 31889409
[TBL] [Abstract][Full Text] [Related]
19. Nutritional phases in Prader-Willi syndrome.
Miller JL; Lynn CH; Driscoll DC; Goldstone AP; Gold JA; Kimonis V; Dykens E; Butler MG; Shuster JJ; Driscoll DJ
Am J Med Genet A; 2011 May; 155A(5):1040-9. PubMed ID: 21465655
[TBL] [Abstract][Full Text] [Related]
20. Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings.
Angulo MA; Butler MG; Cataletto ME
J Endocrinol Invest; 2015 Dec; 38(12):1249-63. PubMed ID: 26062517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
